StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Arun Kumar Mantri

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byArun Kumar MantriHorizon: NA (inferred Intraday)28 Jul 2026, 7:26 am ISTvia CNBC Awaaz.

Entry₹1,978.8Inferred
Target₹1,998
Total upside +0.97% (call closed)
Stop loss₹1,957-1.10% risk
At expiry₹1,977.528 Jul 2026, 3:20 pm
Expired-0.07%
Follow Arun Kumar Mantri for new calls(17% target hit, 102 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Jul 2026
2 supporting1 opposing
Supports the BUY call (2)

Sun Pharma announced that Organon shareholders have approved the proposed acquisition, moving forward the company's strategic expansion plans.

BSE · Company Update·24 Jul · 4d ago

(opens in new tab)

3 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·24 Jul · 4d ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Pharma stocks: Sun Pharma, Biocon, Dr Reddy's, Torrent Pharma slip on Trump's generic drug tariff plan

NewsGoogle News·23 Jul · 5d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Arun Kumar Mantri

Every call and its outcome